Generation of leptin-deficient Lepmkyo/Lepmkyo rats and identification of leptin-responsive genes in the liver

Physiological Genomics

Volumn 45, Issue 17, 2013, Pages 786-793

  Aizawa Abe, Megumi ^a,b   Ebihara, Ken ^a,b   Ebihara, Chihiro ^b   Mashimo, Tomoji ^b   Takizawa, Akiko ^b   Tomita, Tsutomu ^b   Kusakabe, Toru ^b   Yamamoto, Yuji ^b   Aotani, Daisuke ^a,b   Yamamoto Kataoka, Sachiko ^b   Sakai, Takeru ^b   Hosoda, Kiminori ^a,b   Serikawa, Tadao ^b   Nakao, Kazuwa ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ENU mutagenesis; Lepmkyo Lepmkyo rat; Lepob Lepob mouse; Leptin responsive gene; Microarray analysis

Indexed keywords

ETHYLNITROSOUREA; FK 506 BINDING PROTEIN; GENOMIC DNA; GLUCOSE; INHIBIN B; INSULIN; LEPTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYC PROTEIN; PERIPLAKIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; GENE EXPRESSION; GENE IDENTIFICATION; GENOTYPE; GLUCOSE BLOOD LEVEL; LEPTIN DEFICIENCY; LIPID METABOLISM; LIVER; LIVER HISTOLOGY; MALE; MICROARRAY ANALYSIS; MOUSE; MUTAGENESIS; NONHUMAN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ENU MUTAGENESIS; LEPMKYO/LEPMKYO RAT; LEPOB/LEPOB MOUSE; LEPTIN RESPONSIVE GENE; MICROARRAY ANALYSIS;

ANIMALS; CODON, NONSENSE; DISEASE MODELS, ANIMAL; ETHYLNITROSOUREA; FATTY LIVER; GENE EXPRESSION; LEPTIN; LIPID METABOLISM; LIVER; MALE; MICE, MUTANT STRAINS; MUTAGENESIS; OBESITY; RATS, MUTANT STRAINS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84883608202     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00040.2013     Document Type: Article

References (28)

1. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549, 1995.
2. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297: 240-243, 2002.
3. Cone RD. The melanocortin-4 receptor. In: The Melanocortin Receptors, edited by Cone RD. Totowa, NJ: Humana, 2000, p. 404-445.
4. Dubuc PU. The development of obesity, hyperinsulinemia, and hypergly-cemia in ob/ob mice. Metabolism 25: 1567-1574, 1976.
5. Ebihara K, Kusakabe T, Hirata M, Masuzaki H, Miyanaga F, Ko-bayashi N, Tanaka T, Chusho H, Miyazawa T, Hayashi T, Hosoda K, Ogawa Y, DePaoli AM, Fukushima M, Nakao K. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab 92: 532-541, 2007.
6. Ebihara K, Ogawa Y, Masuzaki H, Shintani M, Miyanaga F, Aizawa-Abe M, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Gavrilova O, Reitman ML, Nakao K. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 50: 1440-1448, 2001.
7. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156, 1981.
8. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice Hughes IA AM, McCamish MA, O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341: 879-884, 1999.
9. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S. Beneficial effects of leptin on obesity, T cell hyporespon-siveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110: 1093-1103, 2002.
10. Hedbacker K, Birsoy K, Wysocki RW, Asilmaz E, Ahima RS, Farooqi IS, Friedman JM. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 11: 11-22, 2010.
11. Hillebrand JJ, Langhans W, Geary N. Validation of computed tomo-graphic estimates of intra-abdominal and subcutaneous adipose tissue in rats and mice. Obesity 18: 848-853, 2010.
12. Hirabayashi M, Kato M, Aoto T, Ueda M, Hochi S. Rescue of infertile transgenic rat lines by intracytoplasmic injection of cryopreserved round spermatids. Mol Reprod Dev 62: 295-299, 2002.
13. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-377, 1997.
14. Li X, Wu X, Camacho R, Schwartz GJ, LeRoith D. Intracerebroven-tricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms. PLoS One 6: e17058, 2011.
15. Liang CP, Tall AR. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J Biol Chem 276: 49066-49076, 2001.
16. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394: 897-901, 1998.
17. Mashimo T, Yanagihara K, Tokuda S, Voigt B, Takizawa A, Naka-jima R, Kato M, Hirabayashi M, Kuramoto T, Serikawa T. An ENU-induced mutant archive for gene targeting in rats. Nat Gen 40: 514-515, 2008.
18. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 84: 3686-3695, 1999.
19. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystro-phy. J Clin Invest 109: 1345-1350, 2002.
20. Prieur X, Tung YC, Griffin JL, Farooqi IS, O'Rahilly S, Coll AP. Leptin regulates peripheral lipid metabolism primarily through central effects on food intake. Endocrinology 149: 5432-5439, 2008.
21. Sharma A, Bartell SM, Baile CA, Chen B, Podolsky RH, McIndoe RA, She JX. Hepatic gene expression profiling reveals key pathways involved in leptin-mediated weight loss in ob/ob mice. PLoS One 5: e12147, 2010.
22. Takaya K, Ogawa Y, Isse N, Okasaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K, Nakao K. Molecular cloning of rat leptin receptor isoform complementary DNAs-identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun 225: 75-83, 1996.
23. Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, Nakao K, Koletsky RJ. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 14: 130-131, 1996.
24. Tamasi JA, Arey BJ, Bertolini DR, Feyen JH. Characterization of bone structure in leptin receptor-deficient Zucker (fa/fa) rats. J Bone Miner Res 18: 1605-1611, 2003.
25. Tanaka S, Isoda F, Yamakawa T, Ishihara M, Sekihara H. T lym-phopenia in genetically obese rats. Clin Immunol Immunopathol 86: 219-225, 1998.
26. Vaira S, Yang C, McCoy A, Keys K, Xue S, Weinstein EJ, Novack DV, Cui X. Creation and preliminary characterization of a leptin knockout rat. Endocrinology 153: 5622-5628, 2012.
27. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, DiMarchi RD, Furman TC, Hale JE, Hsiung HM, Schoner BE, Smith DP, Zhang XY, Wery JP, Schevitz RW. Crystal structure of the obese protein leptin-E100. Nature 387: 206-209, 1997.
28. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994.